nigel_ten_fleming.jpg

Nigel Ten Fleming

Added by Alice

0 reviews

Listed in Angel investors, Biofuel firms, Biofuel projects, Private equity (PE) investors, Venture capitalists (VCs), Who's Who

Title: CEO and Co-Founder
Employer name: ADVentura Capital SL
Personal LinkedIn profile: es.linkedin.com/in/nigeltenfleming
Company website: http://www.g2bpharma.com/
Work email: NFleming@G2BPharma.com
URL # 1 for additional info: http://www.oneworldhealth.org/press_releases/view/pr_1256834959
URL # 2 for additional info: http://www.forbes.com/profile/nigel-fleming/
URL # 3 for additional info: http://www.24-7pressrelease.com/press-release/nigel-ten-fleming-recognized-by-cambridge-whos-who-for-excellence-in-pharmaceutical-technology-227950.php
Investor type: Angel investor, Venture capital investor, Private equity investor
This firm invests in the following funding stages: Seed stage, Early stage
This firm invests in the following industries: Biofuel, Distributed generation

Dr. Nigel T. Fleming is CEO and Co-Founder at ADVentura Capital SL, Executive Chairman at A-CUBE, Inc., Chairman & Chief Executive Officer at Minerva Healthcare, Inc., Chairman & Chief Executive Officer at G2B Pharma, Inc., and Independent Director at Impax Laboratories, Inc. He is on the Board of Directors at Impax Laboratories, Inc. and Genmedica Therapeutics SL.

Dr. Fleming was previously employed as Chief Executive Officer by BioVision, Inc., Chief Executive Officer by Genica Pharmaceuticals Corp., Chairman, CEO & VP-Business Development by Athena Diagnostics, Inc., and Lecturer by Harvard University. He also served on the board at Examplar, The Institute for OneWorld Health, Athena Neurosciences, Inc., and Elan Pharmaceuticals, Inc.

He received his undergraduate degree from the University of North Carolina at Chapel Hill and a doctorate degree from the University of Cambridge.

Add Your Review

Please login or register to add your review.

Vantage Theme – Powered by WordPress.
Skip to toolbar